| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Elsulfavirine |
Elsulfavirine |
868046-19-9 |
详细
|
| 3,4,5-Trimethoxybenzaldehyde |
3,4,5-三甲氧基苯甲醛 |
86-81-7 |
详细
|
| Pyrimorph |
丁吡吗啉 |
868390-90-3 |
详细
|
| Iristectorigenin B |
鸢尾甲黄素B |
86849-77-6 |
详细
|
| IN-1130 |
IN 1130 |
868612-83-3 |
详细
|
| FINO2 |
FINO2 |
869298-31-7 |
详细
|
| Eg5 Inhibitor V, trans-24 |
869304-55-2 |
869304-55-2 |
详细
|
| Isolindleyin |
异莲花掌苷 |
87075-18-1 |
详细
|
| AC-261066 |
化合物 T14089 |
870773-76-5 |
详细
|
| Mulberrofuran G |
桑呋喃 G |
87085-00-5 |
详细
|
| DRAK2-IN-1 |
DRAK2-IN-1 |
871837-60-4 |
详细
|
| PRL-3 Inhibitor I |
PRL-3 INHIBITOR I |
893449-38-2 |
详细
|
| 4SC-203 |
4SC-203 |
895533-09-2 |
详细
|
| DTHIB |
Urea, N-(4-chloro-3-nitrophenyl)-N'-(4-fluorophenyl)- |
897326-30-6 |
详细
|
| LpxH-IN-AZ1 |
LpxH-IN-AZ1 |
901260-40-0 |
详细
|
| E7016 |
化合物E7016 |
902128-92-1 |
详细
|
| Fucoidan |
岩藻多糖 |
9072-19-9 |
详细
|
| Chymostatin |
胰凝乳蛋白酶抑制剂 |
9076-44-2 |
详细
|
| AS1810722 |
化合物AS1810722 |
909561-15-5 |
详细
|
| Dasatinib N-oxide |
达沙替尼N氧化物 |
910297-52-8 |
详细
|
| Gemigliptin |
吉格列汀酒石酸盐 |
911637-19-9 |
详细
|
| CMPDA |
912574-69-7 |
912574-69-7 |
详细
|
| ABBV-318 |
1-CYCLOPENTYL-1,2-DIHYDRO-6',10',12'-TRIOXASPIRO[INDOLE-3,4'-TRICYCLO[7.3.0.0^{3,7}]DODECANE]-1',3'(7'),8'-TRIEN-2-ONE |
912656-34-9 |
详细
|
| Ziconotide acetate |
醋酸齐考诺肽 |
914454-03-8 |
详细
|
| Indimitecan |
茚替康 |
915360-05-3 |
详细
|
| Felcisetrag |
916075-84-8 |
916075-84-8 |
详细
|
| JH-XVI-178 |
7BIO |
916440-85-2 |
详细
|
| TC-I 15 |
TC-I 15 |
916734-43-5 |
详细
|
| SCH529074 |
SCH 529074 |
922150-11-6 |
详细
|
| P53R3 |
P53R3 |
922150-12-7 |
详细
|
| 2-Phenyl-2-(1-piperidinyl)propane |
1-(1-甲基-1-苯基乙基)哌啶 |
92321-29-4 |
详细
|
| HBX 41108 |
7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 |
924296-39-9 |
详细
|
| BT44 |
BT-44 |
924759-42-2 |
详细
|
| AMTB hydrochloride |
N-(3-AMINOPROPYL)-2-[(3-METHYLPHENYL)METHOXY]-N-(2-THIENYLMETHYL)BENZAMIDE HYDROCHLORIDE |
926023-82-7 |
详细
|
| PQ-10 |
6,7-二甲氧基-4-[(3R)-3-(2-喹喔啉基氧基)-1-吡咯烷基]喹唑啉 |
927691-21-2 |
详细
|
| Naphthol AS-E |
色酚 AS-E |
92-78-4 |
详细
|
| AS1892802 |
AS 1892802 |
928320-12-1 |
详细
|
| HPN-01 |
HPN-01 |
928655-63-4 |
详细
|
| 4-MMPB |
15-Lipoxygenase Inhibitor 1 |
928853-86-5 |
详细
|
| IA-Alkyne |
N-己-5-炔基-2-碘乙酰胺 |
930800-38-7 |
详细
|
| Dusquetide |
Serlopitant |
931395-42-5 |
详细
|
| DMT-dG(ib) Phosphoramidite |
DMT-dG(ib)亚磷酰胺单体 |
93183-15-4 |
详细
|
| 2-(Aminomethyl)phenol |
2-羟基苄胺 |
932-30-9 |
详细
|
| Chamaechromone |
狼毒色原酮 |
93413-00-4 |
详细
|
| QM31 |
QM31 |
937735-00-7 |
详细
|
| Difamilast |
地法米司特 |
937782-05-3 |
详细
|
| (±)-N-3-Benzylnirvanol |
(+/-)-N-3-Benzylnirvanol |
93879-40-4 |
详细
|
| p53 and MDM2 proteins-interaction-inhibitor (chiral) |
2-[4-[[(4S,5R)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-吗啡啉)乙酮 |
939981-37-0 |
详细
|
| BAZ1A-IN-1 |
化合物BAZ1A-IN-1 |
941521-45-5 |
详细
|
| JK-P3 |
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺 |
942655-44-9 |
详细
|
| Cromakalim |
色满卡林 |
94470-67-4 |
详细
|
| C3a receptor agonist 1 |
2-环己基-2-苯基-N-[1-(3-吡啶-3-基丙酰基)哌啶-4-基]乙酰胺 |
944997-60-8 |
详细
|
| Gypenoside L |
绞股蓝皂苷L |
94987-09-4 |
详细
|
| Ipragliflozin (L-Proline) |
伊格列净L-脯氨酸 |
951382-34-6 |
详细
|
| Icerguastat |
化合物SEPHIN 1 |
951441-04-6 |
详细
|
| Garcinone C |
4-氨基-1-叔丁基-3-(3-甲基苄基)吡唑并[3,4-D]嘧啶 |
956025-83-5 |
详细
|
| Isolinderalactone |
异乌药内酯 |
957-66-4 |
详细
|
| NCT-58 |
4-[[4-氨基-6-(5-氯-1H,3H-萘并[1,8-CD]吡喃-6-基)-1,3,5-三嗪-2-基]硫基]丁酰胺 |
959763-06-5 |
详细
|
| (E)-Akt inhibitor-IV |
CS-1992 |
959841-49-7 |
详细
|
| (±)-Stylopine hydrochloride |
盐酸人血草碱 |
96087-21-7 |
详细
|
| DPI 201-106 |
SDZ-201 106 (+/-) |
97730-95-5 |
详细
|
| Drotaverine hydrochloride |
盐酸屈他维林 |
985-12-6 |
详细
|
| Yadanzioside I |
鸦胆子苷I |
99132-95-3 |
详细
|
| Acetylcholine-d |
(-)-白玉兰亭 B |
87402-88-8 |
详细
|
| SEN12333 |
SEN 12333 |
874450-44-9 |
详细
|
| Quisinostat dihydrochloride |
QUISINOSTAT 二盐酸盐 |
875320-31-3 |
详细
|
| N-Arachidonyl maleimide |
N-花生四烯基马来酰亚胺 |
876305-42-9 |
详细
|
| Nucleoside-Analog-1 |
876707-99-2 |
876707-99-2 |
详细
|
| Nucleoside-Analog-2 |
876708-01-9 |
876708-01-9 |
详细
|
| GSK5182 |
CS-2620 |
877387-37-6 |
详细
|
| 2,6-Dimethylquinoline |
2，6-二甲基喹啉 |
877-43-0 |
详细
|
| THP104c |
化合物THP104C |
877792-12-6 |
详细
|
| (E)-[6]-Dehydroparadol |
878006-06-5 |
878006-06-5 |
详细
|
| Phthalazinone pyrazole |
Phthalazinone pyrazole |
880487-62-7 |
详细
|
| Cinnamtannin B-1 |
桂皮鞣质B1 |
88082-60-4 |
详细
|
| HIF-2α-IN-4 |
HIF-2a Translation Inhibitor 76 |
882268-69-1 |
详细
|
| CCT129957 |
CCT129957 |
883098-58-6 |
详细
|
| SSAA09E2 |
SSAA09E2 |
883944-52-3 |
详细
|
| FBPase-1 inhibitor-1 |
FBPase-1 Inhibitor |
883973-99-7 |
详细
|
| M8-B |
N-(2-AMINOETHYL)-N-(4-(BENZYLOXY)-3-METHOXYBENZYL)THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE |
883976-12-3 |
详细
|
| c-Fms-IN-3 |
4-氰基-N-[4-(4-甲基-1-哌嗪基)-2-(4-甲基-1-哌啶基)苯基]-1H-吡咯-2-甲酰胺 |
885704-21-2 |
详细
|
| NY2267 |
化合物NY2267 |
886053-73-2 |
详细
|
| CAY10502 |
CAY10502 |
888320-29-4 |
详细
|
| Heclin |
(E)-N-(4-acetylphenyl)-3-(5-ethylfuran-2-yl)prop-2-enamide |
890605-54-6 |
详细
|
| ML-SI3 |
ML-SI3 |
891016-02-7 |
详细
|
| EAAT2 activator 1 |
化合物T9347 |
892415-28-0 |
详细
|
| STD1T |
STD1T |
893075-58-6 |
详细
|
| Eph inhibitor 1 |
3-(7-amino-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenol |
861249-77-6 |
详细
|
| IM-54 |
Necrosis Inhibitor, IM-54 |
861891-50-1 |
详细
|
| N106 |
N-(4-甲氧基苯并[D]噻唑-2-基)-5-(4-甲氧基苯基)-1,3,4-噁二唑-2-胺 |
862974-25-2 |
详细
|
| Dasatinib monohydrate |
达沙替尼一水合物 |
863127-77-9 |
详细
|
| TM6089 |
TM6089 |
863421-32-3 |
详细
|
| Methoxy-X04 |
Methoxy-X04 |
863918-78-9 |
详细
|
| Fluoroquinolonic acid |
环丙羧酸 |
86393-33-1 |
详细
|
| ARN5187 trihydrochloride |
化合物NAE-IN-M22 |
864420-54-2 |
详细
|
| L-Tyrosine-d |
苯那普利拉 |
86541-78-8 |
详细
|
| 3,4,5-Tricaffeoylquinic acid |
3,4,5-三咖啡酰奎宁酸 |
86632-03-3 |
详细
|
| GW280264X |
((S)-5-((2R,3S)-3-(N-羟基甲酰胺基)-2-异丁基六氨基)-2-氧代-6-(噻唑-2-基氨基)己基)氨基甲酸苄酯 |
866924-39-2 |
详细
|
| Depulfavirine |
RO0335 |
867365-76-2 |
详细
|
| (R)-Trolox |
VC乙基醚 |
86404-04-8 |
详细
|